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Abstract Myrica nagi (family Myricaceae) is commonly
known as Kathphal (Hindi) and Bayberry (English) and it
has a long history of usage in traditional medicine. It is pop-
ular actinorhizal plant for its symbiotic relationship with
Frankia. This study was taken in force to estimate the analge-
sic, anti-inflammatory and anti-oxidative activities of metha-
nolic extract of Myrica nagi (MMN) in an animal model.
Anti-oxidative property of MMN was assessed by free radical
scavenging assay (DPPH method). The acute toxicity test of
methanolic extract of MMN revealed that the median lethal
dose (LD50) was found to be 2080 mg/kg body weight in
mice. The anti-inflammatory property was evaluated by
carrageenan-induced acute inflammation in rats by measuring
rat paw volume at different time intervals and toxicological
analysis using mice. The analgesic effect was measured in
Wistar rats using the acetic acid-induced writhing test and
MMN at 200 mg/kg BW showed 54.56 % inhibition of writh-
ing. MMN showed higher anti-oxidant activity in DPPH as-
says as compared to standard. High dose of MMN showed a
significant reduction (21.71 %) in inflammation after 4 h of
treatment, which was comparable to diclofenac (10 mg/kg
BW; 32.75 %)-treated group. Significant reduction (p<0.05)
in the levels of inflammatory cytokine (IL-1β and TNF-α)
markers were also observed in serum of MMN-treated ani-
mals as compared to control. Taken together, the phenolic
compounds of MMN may serve as potential herbal drug for
amelioration of acute inflammation due to their modulatory
action on free radicals.
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1 Introduction
Myrica nagi Thunb. (family Myricaceae) popularly known as
Bayberry is variously referred as Kathphal (Hindi), Sohphi
(Khasi) and Nagatenga (Assamese).M. nagi is an actinorhizal
plant. Actinorhizal plants are well known for their ability to
form root nodules in symbiotic association with the soil acti-
nomycete Frankia and are capable of high rates of nitrogen
fixation, comparable to those of legumes. It is mostly ever-
green, dioecious and is distributed in the subtropical Himalaya
from Ravi, eastwards to Assam and in Khasi Hills, Jaintia
Hills, Naga Hills and Lushai Hills at an elevation of about
900-1200 m above mean sea level (Panthari et al. 2012). In
Meghalaya, three different morphotypes ofMyrica have been
reported viz. M. esculenta, M. nagi and the third intermediate
between the two (Yanthan and Mishra 2013).
Inflammation is a host defence mechanism which is in
response to noxious stimuli. It is charecterised by redness of
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skin, pain, warmth swelling and loss of function.
Inflammation plays an important role in various diseases such
as rheumatoid arthritis, ulcer, atherosclerosis, and asthma.
Many drugs that are available in the market for inflammatory
diseases exhibit several side effects to humans. Therefore,
there is a need for alternative treatments with safer com-
pounds. Every part of M. nagi is precious in Ayurveda as
medicine for combating several ailments since ancient times
(Silva et al. 2015). Anti inflammatory activity of ethyl acetate
and aqueous extracts of bark ofM. nagi at 100 and 200 mg/Kg
BW using carrageenan and histamine induced rat paw edema
exhibited about 28 and 18 % in wistar rats. While information
is available on the medicinal property of M. nagi bark (Khan
et al. 2008; Patel et al. 2011; Panthari et al. 2012) and fruits
(Mannello 2006), such information is severely lacking for the
leaves. This study therefore investigates the leaves ofM. nagi
for their anti-inflammatory, analgesic and anti-oxidative activ-
ities. To our knowledge, the current investigations will be the
first report on analgesic, anti-oxidative and anti-inflammatory
properties of M. nagi leaves so far.
2 Materials and methods
2.1 Plant material collection and extraction
M. nagi leaves were collected from the fields of North Eastern
Hill University (NEHU) Campus, Shillong, Meghalaya, India
during February, 2014. The plant material was authenticated
by a plant taxonomist and a voucher specimen (Voucher No.
9659) was deposited at Department of Botany, University of
North Bengal, West Bengal, India. The material was shade
dried and ground to fine powder. The pulverized leaves
(10 g each) were extracted by Soxhlation using methanol
(plant: solvent 1:15 w/v) (Middha et al. 2011) for 6 h. The
methanolic extract of M. nagi leaves (MMN) was dried with
the help of a rotary vacuum evaporator (Middha et al. 2011)
and stored at 4 °C until required.
2.2 In vitro antioxidant property (DPPH method)
The antioxidant activity of MMN and the standard were
assessed on the basis of the scavenging effect of the stable 2,
2-diphenyl-1-picryl-hydrazyl (DPPH) free radical as per the
modified protocol by Goyal and his co-workers (Goyal et al.
2010). The DPPH solution (0.006 % w/v) was prepared in
95 % methanol. Freshly prepared DPPH solution was added
to all test tubes. The extract was pipetted out in different ali-
quots (100-1000 μg) and the final volume was made up to
2 mL. The discoloration of the reaction mixture was measured
at wavelength 517 nm after 30 min of incubation in the dark.
The experiment was performed at least in triplicates. Ascorbic
acid was used as a reference standard and dissolved in double
distilled water (DDW) to make the stock solution with the
same concentration (1 mg/mL). The solvent methanol
(95 %) was used as blank. Percentage scavenging of the
DPPH free radical was measured using the equation:
Percentage scavenging ¼ A0−A1=A0  100
where A0 is the absorbance of the control and A1 is the absor-
bance of the sample. The actual decrease in absorption in-
duced by the test extract was compared with the positive con-
trol. The IC50 value was calculated using the dose inhibition
curve. IC50 is the desired drug concentration requires produc-
ing 50 % inhibition.
2.3 In vivo assays
2.3.1 Animals
Male Wistar albino rats (140–160 g) were housed under stan-
dard laboratory conditions of light and dark cycles of 7:00 am
to 7:00 pm, temperature of 25 °C±2 °C and 68 %±1 % rel-
ative humidity. The animals were provided standard rat pellet
(Lipton India Ltd., Bangalore, India) and tap water ad libitum.
All animal procedures were carried out in strict compliance
with the Institutional Animal Ethics Committee regulations.
The study protocol was approved by Maharani Lakshmi
Ammanni College Ethical Committee, clearance from ethical
committee (1368/ac/10/CPCSEA), Bangalore, India.
2.3.2 Acute toxicity test
Swiss albino mice (25–30 g) of both sexes were divided into
six groups of 10 each. Animals were fasted overnight and
were free to access water preceding the experiment. MMN
was administered to each group at different dose levels of
0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 g/kg Body weight (BW)/mL.
The mice were critically observed for 24 h, mortality was
recorded and LD50 (median lethal dose) was determined as
per previous study (Middha et al. 2011).
2.3.3 Analgesic activity
Acetic acid-induced writhing test: The writhing test for anal-
gesic activity was performed according to the method de-
scribed by Mohanty et al. (2015). The Wister albino rats were
divided in to five groups with six randomly selected animals
in each group. All animals were fasted 24 h prior to start of the
experiment and had free access to water. Group I was consid-
ered normal treated with water alone (NL), group II was treat-
ed as the control administered with vehicle only (acetic acid
1 % v/v), group III and IV received low dosage of M. nagi
methanolic leaf extract (LMMN) and high dosage of M. nagi
methanolic leaf extract (HMMN) at 100 and 200 mg/Kg body
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weight (BW) respectively, and group V was given with the
standard drug diclofenac sodium (10 mg/Kg; Sigma Chemical
Co., St. Louis, MO, USA). After 1 h of treatment, writhing
was induced by intra-peritoneal injection of 1 % acetic acid
(1 mL/Kg BW). The writhing response was observed by
counting the total number of writhes after 5 min of injection
of acetic acid during 20 min. Data were recorded as mean
number of writhes from each group and the percentage of
inhibition was calculated according to the following formula.
% inhibition ¼ Wc−Wtð Þ*100f g=Wc
where Wc is average number of writhing in control group and
Wt is average number of writhing in treated group.
2.3.4 Anti-inflammatory activity
The carrageenan-induced rat paw edema test (Winter et al.
1962) has been used as an experimental model for testing
the anti-inflammatory activity as per previous report
(Mohanty et al. 2015). One hour after oral administration of
LMMN and HMMN or diclofenac, carrageenan-saline solu-
tion (0.5 % w/v) and saline were injected in a volume of
0.1 mL into the plantar surface of the right and left hind
paw, respectively. The left paw served as the control (non-
inflamed) paw. The experimental animals were observed for
0 h, 1 h, 2 h and 4 h; the paw volume was measured using a
plethysmometer. The anti-inflammatory effect was calculated
as per the equation below:
Anti‐inflammatory effect %ð Þ ¼ k−e=k  100
where k is the difference in the paw weight in the control
group and e is the difference in the pawweight in the treatment
group. After treatments, rats were euthanized using combina-
tion of 0.15 ml/100 g xylazine (30 mg/kg BW) and 0.3 ml/
100 g i.p ketamine (300 mg/kg BW ) as proposed by
Committee for the Purpose of Control and Supervision of
Experiments on Animals (CPCSEA). Blood samples were
collected by retro-orbital puncture from all rats and serum
was separated for further biochemical estimations.
2.3.5 Measurement of IL-1β and TNF-α levels
The serum concentrations of interleukin=1 beta (IL-1β) and
tumor necrosis factor-alpha (TNF-α) (Endogen, Woburn,
MA, USA) were measured using a commercial enzyme-
linked immunosorbent assay (ELISA) kit method
(Biosource, San Diego, CA, USA) (Comalada et al. 2005).
2.4 Statistical analysis
All the experiments were repeated six times and
expressed as mean ± standard error of means (SEM)
and statistically analyzed by two-way analysis of vari-
ance followed by Tukey’s multiple range using
GraphPad prism 5. p< 0.005 and p< 0.01 were consid-
ered to be statistically significant.
3 Results and discussion
3.1 DPPH scavenging activity of M. nagi
The radical scavenging activity, using a DPPH generat-
ed radical, was tested at different concentrations ranging
from 10 to 100 mg/ml for MMN (Fig. 1). The values
for maximum % inhibition at 10 to 100 mg/ml ranged
from 17.15 to 67.34 % in MMN, whereas that of stan-
dard (ascorbic acid) was found to be 11.75 and 34.23 %
for 10 and 100 mg/ml concentration, respectively. The
high DPPH scavenging activities of the methanolic ex-
tract have already been reported by other researchers in
other plants (Goyal et al. 2011a; Goyal et al. 2011b).
IC50 of MMN was found to be 3.34 mg/ml.
DPPH is a stable free radical and its activity is based
on its ability to decolorize from deep purple colour at a
wavelength 517 nm to light yellow in the presence of
antioxidants forming a stable DPPH molecule (Goyal
et al. 2013). MMN showed an effective radical scaveng-
ing ability by this assay.
3.2 Acute toxicity
In vivo median lethal dose or LD50 of MMN was 2080 mg/kg
BW by oral route. Other parameters such as body weight and
survival rate showed no side effects to MMN (data not
shown). LD50 is a parameter to calculate toxicity of a sample
that kills 50 % of the population and expressed in mg/ml per
kg BW.
In vivo toxicological estimation was done to evaluate
the extent to which a drug can cause deleterious effects
to the cell; these tests are essential and widely accepted
to determine optimum drug concentration to be admin-
istered. LD50 of MMN was measured to check lethal
toxicity. Treatment with MMN at a dose of 100 mg/kg
and 200 mg/kg to their respective group of mice for
1 month did not show any toxic side effect.
3.3 Analgesic activity
The results depicted in Table 1 showed that both the
doses (100 mg/kg and 200 mg/kg) of MMN were effec-
tive in pain relief in a dose-dependent manner. After
oral administration of the extract at both the doses the
maximum inhibition was observed (77.09 %) in the
higher dose i.e. 200 mg/kg of MMN. However, the
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inhibitory effect of the standard drug diclofenac was
found to be greater than both the doses.
Acetic acid-induced writhing involving supraspinal
nociceptors signifies non-steroidal anti-inflammatory
drug (NSAID) type of analgesia (Vedhanayaki et al.
2003). It is a well-documented protocol for evaluating
analgesic activity (Mohanthy et al. 2015). The sensation
of pain is elicited by invigorating some pain mediators
like arachidonic acid from tissue phospholipid via cy-
clooxygenase (COX) (Duarte et al. 1988; Ahmed et al.
2006). This event might be in conjunction with the el-
evated level of prostaglandin E2 and prostaglandin F2α
along with lipoxygenase products in the peritoneal
fluids which in turn augments inflammatory pain by
increasing capillary permeability (Zakaria et al. 2008).
The possible mechanism by which an agent will sup-
press the writhings rendering analgesic effect is proba-
bly by inhibition of prostaglandin synthesis, a peripheral
mechanism of pain inhibition (Zulfiker et al. 2010). In
our study, prominent inhibition of writhing reflux was
observed in both the doses of M. nagi methanolic leaf
extracts. The significant reduction in pain might be at-
tributed to the analgesic ingredients present in M. nagi
leaves acting within the prostaglandin pathways or indi-
rectly by releasing pain mediators.
3.4 Anti-inflammatory activity
3.4.1 Carrageenan-induced paw edema
A number of experimental methods are employed to
access the anti-inflammatory activity. We opted for
carrageenan-induced paw edema model since it is con-
sidered to be the most suitable and widely used test
system for anti-inflammatory activity of natural prod-
ucts (Viana et al. 2011). Being a biphasic process of
2 h each, the carrageenan-induced edema is character-
ized by initial release of histamine, serotonins in the
first 2 h followed by the release of prostaglandin,
bradykinins, leukotrienes and kinin in the later stage
(Usha et al. 2014). The mean increase in paw volume
and percentage of edema inhibition from 0 h up to 4 h
with different concentrations of the extract, standard
and control is represented in Table 2. The result re-
Fig. 1 DPPH scavenging activity
of methanolic extract of Myrica
nagi leaves
Table 1 Analgesic activity by
methanolic extract of M. nagi
leaves in experimental rats
Experimental Animals Dosages (mg/kg) No of Writhing Percent Inhibition
NL No induction 2.60± 0.09 –
AA(1%v/v) No treatment 41.13 ± 4.56 a –
AA+LMMN 100 mg/kg 42.17 ± 2.56 a −2.46 ↑
AA+HMMN 200 mg/kg 23.16 ± 2.20 b +77.59↓
AA+Diclofenac 10 mg/kg 4.80± 0.18 c +177.09↓
NC, Normal Control; AA, Control Acetic Acid (1%v/v); AA + LMMN, LowMN (100 mg/Kg body weight); AA
+ HMMN, High MN (200 mg/Kg body weight). Data represented as mean% ± SEM for number of animals = 6.
*p < 0.05 (one way ANOVA and Tukey’s test). Different subscripts denotes significant group at p< 0.05 vs.
inflammatory group (IC); NS indicates not significant
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vealed that MMN significantly (p < 0.01) produced a
dose-dependent inhibition of paw edema which was
compa r a b l e t o t h e e f f e c t o f a known an t i -
inflammatory drug, diclofenac in the experimental rats
at fourth hour. The reduction in carrageenan-induced
paw edema by HMMN after 4 h was 21.71 % while
edema reduction by the standard drug, diclofenac
(10 mg/kg) was 32.75 % (Table 2). Our in vivo results
were in strongly proof and in accordance to previous
studies in other plant species (Usha et al. 2014;
Mohanthy et al. 2015).
3.4.2 Effect of MMN on various cytokine levels
The roles of natural product obtained from plants have
been well documented in treatment of both acute and
chronic inflammatory diseases. Cytokines, small glyco-
proteins play crucial role in elicitation of inflammatory
reaction. Each of the cytokines (IL-1β and TNF-α) test-
ed here are critically involved in controlling innate as
well as adaptive inflammatory response (Loram et al.
2007). The level of these cytokines should be sup-
pressed to reduce the severity of the inflammatory reac-
tion. In the present study, the regulation of IL-1β and
TNF-α in serum were determined to access the anti-
inflammatory activity of both HMMN and LMMN in
comparison to the reference drug (diclofenac) and con-
trol. It is evident from the Fig. 2 that inflammatory
reaction induced by carrageenan significantly increased
concentration of IL-1β and TNF-α (p< 0.05) in serum.
Though both the doses were found to be effective in
reducing the levels of cytokines in the serum signifi-
cantly as compared to the inflammation-induced groups,
HMMN was more effective.
Table 2 Paw volume variation
due to anti-inflammatory effects
of methanolic extracts of M. nagi
leaves






NL – 2.60 ± 0.09 2.90 ± 0.01 2.20 ± 0.01
IC No treatment 41.13 ± 4.56 39.21 ± 9.01a 62.48 ± 10.14a
IC +LMMN 100 42.76 ± 1.93NS 08.90 ± 0.50b 14.87 ± 6.11 a
IC +HMMN 200 43.73 ± 1.60 NS 18.58 ± 6.01c 21.71 ± 7.24 a
IC +Diclofenac 10 44.68 ± 0.99a 30.80 ± 0.01 c 32.75 ± 3.19 b
NC, Normal Control; IC, Carrageenan Control; IC + LMMN, LowMN (100mg/Kg body weight); IC + HMMN,
High MN (200 mg/Kg body weight). Data represented as mean% ± SEM for number of animals = 6. *p< 0.05
(one way ANOVA and Tukey’s test). Different subscripts denotes significant group at p< 0.05 vs. inflammatory
group (IC); NS indicates not significant
Fig. 2 Effects of methanolic extracts of M. nagi leaves on the levels of cytokines in experimental rats
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4 Conclusions
In conclusion, we can infer that the methanolic extract of
Myrica nagi leaves is a potential source of natural antioxi-
dants. In addition to this our findings provide scientific ratio-
nale for the folk use of Myrica nagi as an analgesic and anti-
inflammatory shrub. However, further study is needed in order
to understand the precise mechanism and be totally authentic.
Phytochemical characterization and phramacodynamics stud-
ies are also proposed to isolate the active constituents and
establish the mechanism of action.
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